Open Access
Med Sci (Paris)
Volume 37, Number 10, Octobre 2021
Page(s) 873 - 881
Section M/S Revues
Published online 14 October 2021
  1. Daguerre A. Les grossesses en France et en Grande-Bretagne. Un phénomène dérangeant pour les pouvoirs publics. Informations Sociales 2010; 96–102. [Google Scholar]
  2. Vilain A. Les interruptions volontaires de grossesse en 2020. Études et Résultats: Paris, DREES, 2019. [Google Scholar]
  3. Kirbas AGulerman HCDaglar KPregnancy in adolescence: is it an obstetrical risk?. J Pediatr Adolesc Gynecol 2016 ; 29 : 367–371. [CrossRef] [PubMed] [Google Scholar]
  4. Bajos NRouzaud-Cornabas MPanjo H, et al. La crise de la pilule en France : vers un nouveau modèle contraceptif ?. Population et Sociétés 2014 ; 511 [Google Scholar]
  5. True KBajos NBohet A, et al. Timing of contraceptive initiation and association with future sexual and reproductive outcomes. Hum Reprod 2014 ; 29 : 1651–1658. [CrossRef] [PubMed] [Google Scholar]
  6. Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 2020; 383 : 1340–8. [CrossRef] [PubMed] [Google Scholar]
  7. Steiner RJLiddon NSwartzendruber AL, et al. Long-acting reversible contraception and condom use among female us high school students: implications for sexually transmitted infection prevention. JAMA Pediatr 2016 ; 170 : 428–434. [CrossRef] [PubMed] [Google Scholar]
  8. Jousselme C, Cosquer M, Hassler C. Portraits d’adolescents. Enquête épidémiologique en mileu scolaire en 2013. Paris : Inserm, 2015. [Google Scholar]
  9. Trussell J.Contraceptive failure in the United States. Contraception. 2011 ; 83 : 397–404. [CrossRef] [PubMed] [Google Scholar]
  10. Mansour DInki PGemzell-Danielsson KEfficacy of contraceptive methods: a review of the literature. Eur J Contracept Reprod Health Care 2010 ; 15 : (suppl 2)S19–S31. [CrossRef] [PubMed] [Google Scholar]
  11. Secura GMMadden TMcNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med 2014 ; 371 : 1316–1323. [CrossRef] [PubMed] [Google Scholar]
  12. Moreau CBohet AHassoun D, et al. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010. Fertil Steril 2013 ; 100 : 451–458. [Google Scholar]
  13. Plu-Bureau GMaitrot-Mantelet LHugon-Rodin J, et al. Hormonal contraceptives and venous thromboembolism: an epidemiological update. Best Pract Res Clin Endocrinol Metab 2013 ; 27 : 25–34. [CrossRef] [PubMed] [Google Scholar]
  14. Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014; CD003987. [PubMed] [Google Scholar]
  15. Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2012; CD004425. [PubMed] [Google Scholar]
  16. Malmborg APersson EBrynhildsen J, et al. Hormonal contraception and sexual desire: a questionnaire-based study of young Swedish women. Eur J Contracept Reprod Health Care 2016 ; 21 : 158–167. [CrossRef] [PubMed] [Google Scholar]
  17. Barnett CHagemann CDinger J, et al. Fertility and combined oral contraceptives – unintended pregnancies and planned pregnancies following oral contraceptive use – results from the INAS-SCORE study. Eur J Contracept Reprod Health Care 2017 ; 22 : 17–23. [CrossRef] [PubMed] [Google Scholar]
  18. Stoddard AMXu HMadden T, et al. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care 2015 ; 20 : 223–230. [CrossRef] [PubMed] [Google Scholar]
  19. Morch L.S.Skovlund C.W.Hannaford P.C., et al. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 2017 ; 377 : 2228–2239. [CrossRef] [PubMed] [Google Scholar]
  20. Iversen LFielding SLidegaard Ø, et al. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 2018 ; 362 : k3609. [PubMed] [Google Scholar]
  21. Collaborative group on epidemiological studies on endometrialC. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol 2015 ; 16 : 1061–1070. [CrossRef] [PubMed] [Google Scholar]
  22. Barchrach L.K. Hormonal contraception and Bone health in adolescents and contraceptives. Front Endocrinol 2020; 11 : 603. [Google Scholar]
  23. Bahamondes LBahamondes VMShulman LPNon-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update 2015 ; 21 : 640–651. [CrossRef] [PubMed] [Google Scholar]
  24. Davis ARWesthoff CO’Connell K, et al. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 2005 ; 106 : 97–104. [CrossRef] [PubMed] [Google Scholar]
  25. Harada TMomoeda MTaketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008 ; 90 : 1583–1588. [CrossRef] [PubMed] [Google Scholar]
  26. Haamid FSass AEDietrich JEHeavy menstrual bleeding in adolescents. J Pediatr Adolesc Gynecol 2017 ; 30 : 335–340. [CrossRef] [PubMed] [Google Scholar]
  27. Dokras A.Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits. Fertil Steril 2016 ; 106 : 1572–1579. [CrossRef] [PubMed] [Google Scholar]
  28. Grimes DA, Jones LB, Lopez LM, et al. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev 2014; CD006134. [PubMed] [Google Scholar]
  29. Quint EHMenstrual and reproductive issues in adolescents with physical and developmental disabilities. Obstet Gynecol 2014 ; 124 : 367–375. [CrossRef] [PubMed] [Google Scholar]
  30. Chabbert-Buffet NMarret HAgostini A, et al. Clinical practice guidelines for contraception by the French national college og gynecologists and obstetricians. Gynecol Obstet Hum Reprod 2019 ; 48 : 441–454. [Google Scholar]
  31. Committee on A. Contraception for adolescents. Pediatrics 2014; 134 : e1244–5. [CrossRef] [PubMed] [Google Scholar]
  32. Committee on Adolescent HealthC. Committee opinion no 699: adolescent pregnancy, contraception, and sexual activity. Obstet Gynecol 2017 ; 129 : e142–e1e9. [CrossRef] [PubMed] [Google Scholar]
  33. Bahamondes MV, Bahamondes L. Intrauterine device use is safe among nulligravidas and adloescent girls. Acta Obstet Gynecol Scand 2021; 100 : 641–8. [PubMed] [Google Scholar]
  34. Modesto WBahamondes MVBahamondes LA randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Hum Reprod 2014 ; 29 : 1393–1908. [PubMed] [Google Scholar]
  35. Darney PPatel ARosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009 ; 91 : 1646–1653. [PubMed] [Google Scholar]
  36. Oringanje C, Meremikwu MM, Eko H, et al. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev 2016; 2 : CD0052. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.